Skip to main content

Eltoukhy Helmy's Form 4 filing

Guardant Health, Inc. (GH) · filed Jun 8, 2026

Accession no.
0001752968-26-000010
Filed
Jun 8, 2026
Trade date
Jun 5, 2026
Filing delay
3 days
Rule 10b5-1 plan
Not checked

This filing lists 7 non-derivative transactions. Open-market sales total $12.6M. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Eltoukhy HelmyCIK 0001752968Director, Officer (Co-Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 5, 2026Common StockSSaleDisposed−49,716$125.57F1−$6,242,838.122,063,203Indirect
Jun 5, 2026Common StockSSaleDisposed−33,843$126.33F2−$4,275,386.192,029,360Indirect
Jun 5, 2026Common StockSSaleDisposed−1,100$127.02F3−$139,7222,028,260Indirect
Jun 5, 2026Common StockSSaleDisposed−13,787$128.25F4−$1,768,182.752,014,473Indirect
Jun 5, 2026Common StockSSaleDisposed−554$130.21F5−$72,136.342,013,919Indirect
Jun 5, 2026Common StockSSaleDisposed−900$131.78F6−$118,6022,013,019Indirect
Jun 5, 2026Common StockSSaleDisposed−100$132.55−$13,2552,012,919Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $124.95 to $125.94. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F2

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $125.95 to $126.93. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F3

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $126.965 to $127.030. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F4

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $128.250 to $128.335. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F5

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $130.02 to $131.00. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

F6

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $131.36 to $132.18. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)